Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
---|---|---|---|---|---|
Jan. 01, 2021 |
Jul. 22, 2016 |
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
|
Class of Stock [Line Items] | |||||
Property, plant and equipment, gross | $ 12,567 | $ 11,595 | |||
Research and development | 11,618 | $ 9,314 | |||
Construction in Process [Member] | |||||
Class of Stock [Line Items] | |||||
Property, plant and equipment, gross | $ 1,458 | $ 499 | |||
Fortress Biotech, Inc [Member] | |||||
Class of Stock [Line Items] | |||||
Percentage of fully diluted equity | 2.50% | 2.50% | 2.50% |
X | ||||||||||
- Definition Represents the percentage of diluted outstanding equity paid as equity fee or used to calculate stock issuance to maintain parity. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|